Related Experiment Video
Updated: Mar 30, 2026

Orthotopic Implantation of Patient-Derived Cancer Cells in Mice Recapitulates Advanced Colorectal Cancer
Published on: February 10, 2023
Cancer Models and Real-world Data: Better Together
Jane J Kim1, Anna Na Tosteson2, Ann G Zauber2
1Department of Health Policy and Management, Harvard T. H. Chan School of Public Health, Boston, MA (JJK); Department of Medicine and The Dartmouth Institute for Health Policy and Clinical Practice, Geisel School of Medicine at Dartmouth, Lebanon, NH (ANAT); Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY (AGZ); Department of Surgery and University of Vermont Cancer Center, University of Vermont, Burlington, VT (BLS); Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA (NKS); Department of Industrial and Systems Engineering, University of Wisconsin-Madison, Madison, WI (OA); Population Health Sciences and Carbone Cancer Center, University of Wisconsin-Madison, Madison, WI (ATD); Department of Medicine, Massachusetts General Hospital, Boston, MA (KA); Department of Clinical Sciences, University of Texas Southwestern Medical Center, Dallas, TX (SLP); RAND Corporation, Santa Monica, CA (CMR). jkim@hsph.harvard.edu.
Decision-analytic models can be improved by integrating real-world health care data. This enhances cancer screening models to better project outcomes and guide policy for improved screening practices.
Area of Science:
- Health Services Research
- Biostatistics
- Public Health Policy
Background:
- Decision-analytic models are crucial for health policy, synthesizing data to predict long-term outcomes.
- Real-world screening practices in diverse US health systems are complex and challenging to model.
- Existing models often operate under ideal conditions, limiting their applicability to current screening practices.
Purpose of the Study:
- To describe the synergy between decision-analytic models and health care utilization data.
- To explore opportunities for enriching cancer screening models with real-world data.
- To improve the projection of harms and benefits of current cancer screening practices.
Main Methods:
- Leveraging health care utilization data from electronic medical record systems.
- Integrating real-world data to ground and enrich decision-analytic models.
- Utilizing the Population-based Research Optimizing Screening through Personalized Regimens (PROSPR) consortium as a case study.
Main Results:
- Real-world data can enrich cancer screening models, improving their accuracy and applicability.
- Models grounded in real-world data can evaluate new technologies and identify areas for improvement.
- The PROSPR consortium demonstrates a collaborative approach to harmonizing and analyzing screening data.
Conclusions:
- Pairing decision-analytic models with real-world data creates more robust models for policy and practice.
- Improved models can better inform health systems on optimizing cancer screening delivery.
- This approach enhances the ability to project harms, benefits, and value of cancer screening interventions.
Related Concept Videos
Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Mouse Models of Cancer Study
What is Cancer?
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of...
Cancer Survival Analysis

